This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://dx.doi.org/10.3899/
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57673825
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в березні 2010 artículu científicu espublizáu en marzu de 2010 article scientifique publié en 2010 wetenschappelijk artikel scientific article published on 15 March 2010 im März 2010 veröffentlichter wissenschaftlicher Artikel
p:P577
wds:Q57673825-9A0FE780-3520-47E3-B2B2-8F7D8990BF40
wdt:P577
2010-03-15T00:00:00Z
p:P407
wds:Q57673825-244A3DE8-FE92-445D-A071-630847EAB9DD
wdt:P407
wd:Q1860
p:P2093
wds:Q57673825-19985E1B-B4B3-4C46-8469-106EDFB863F7
wdt:P2093
CANDLE Study Group
rdfs:label
A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis
skos:prefLabel
A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis
schema:name
A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis A Double-blind, Placebo-controlled Trial of Low Dose Infliximab in Ankylosing Spondylitis
p:P50
wds:Q57673825-0261A472-1C9C-4106-A4EF-FCFA18D388A5 wds:Q57673825-D0BC6B1E-F6B7-4137-8D32-F9455F283589
wdt:P50
wd:Q51425953 wd:Q87727130
p:P1476
wds:Q57673825-09C2C31F-D429-4F56-A53E-77663136F0B7
wdt:P1476
A double-blind, placebo-controlled trial of low dose infliximab in ankylosing spondylitis
p:P304
wds:Q57673825-D7C6EF72-0F7A-4D2C-B61A-EF975917269E
wdt:P304
1203-1210
p:P31
wds:Q57673825-6B4C6FA5-3DC5-42DE-B8F1-D0EDDDF8815A
wdt:P31
wd:Q13442814
p:P921
wds:Q57673825-1EEFFC28-E20E-4734-9F6E-538400E80A81 wds:Q57673825-80299784-5544-4194-90FA-93AAD8C2F076 wds:Q57673825-FA7E997B-744A-4EA2-BD53-54DD57ED8C98
wdt:P921
wd:Q52849 wd:Q269829 wd:Q108853737
p:P698
wds:Q57673825-6DE20DA9-8950-4469-B667-3CE451B8012A
wdtn:P698
n9:20231198
wdt:P698
20231198
p:P1433
wds:Q57673825-DA936143-FD6E-4D27-BAC8-EB442FB955D6
wdt:P1433
wd:Q7743623
p:P433
wds:Q57673825-29787E18-2EC1-44ED-8880-D302900F1B23
p:P478
wds:Q57673825-BA205E6E-DD6B-4397-A4EB-6EA0EEB7A757
wdt:P433
6
wdt:P478
37
p:P356
wds:Q57673825-2EDF0BD4-FC96-476B-B4F0-4EF1648D3863
wdtn:P356
n12:JRHEUM.091042
wdt:P356
10.3899/JRHEUM.091042